| Pharmaceutical manufacturers GMP |
29 |
46 |
29 |
21 |
30 |
| Preclinical / non-clinical studies GLP |
7 |
7 |
4 |
2 |
7 |
| Clinical trials on medicinal products GCP |
5 |
12 |
13 |
7 |
2 |
| Pharmacovigilance GVP |
1 |
3 |
5 |
2 |
4 |
| Blood services |
8 |
4 |
5 |
6 |
4 |
| Hospital pharmacies and pharmaceutical centres |
21 |
22 |
22 |
14 |
18 |
| Pharmacies and subsidiary pharmacies |
56 |
57 |
75 |
24 |
28 |
| Pharmaceutical wholesalers |
15 |
28 |
30 |
25 |
25 |
| Tissue services providers |
25 |
25 |
24 |
23 |
25 |
| Organ donation and transplantation services |
2 |
6 |
6 |
1 |
0 |
| National ATMP manufacturing licence |
1 |
2 |
1 |
0 |
2 |
| Separate inspection of mandatory reserve supplies |
0 |
0 |
0 |
0 |
0 |
| Separate inspections under the Narcotics Act |
2 |
4 |
3 |
1 |
0 |
| Biobanks |
- |
- |
- |
3 |
8 |
| GMO inspections |
- |
- |
- |
5 |
10 |
| Repository for the safety features of medicinal products and the person managing the repository |
- |
- |
- |
- |
1 |
| Total |
172 |
216 |
217 |
134 |
164 |
| Of which remote inspections |
- |
- |
- |
43 |
74 |
| Hybrid inspections |
- |
- |
- |
15 |
18 |
| Written / documentary inspections |
- |
- |
- |
16 |
4 |
| On site inspections |
- |
- |
- |
- |
68 |
| Total |
- |
- |
- |
74 |
164 |